CACNA1C and Hypertension: Compared to calcium channel blockers to completely ablate the activity of L-type calcium channels, it may be advantageous to partially reduce Ca2+ influx by inhibiting the up-regulation of CaV1.2 channels in cardiovascular diseases, such as hypertension.